Cargando…
Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study
OBJECTIVES: Angiotensin II receptor blockers (ARBs) improve the survival rates of patients with various cancers. However, it remains unclear whether ARBs confer a survival benefit on patients with oral squamous cell carcinoma (OSCC). Here, we assessed the associations between ARB use and survival in...
Autores principales: | Wu, Ching-Nung, Wu, Shao-Chun, Chen, Wei-Chih, Yang, Yao-Hsu, Chin, Jo-Chi, Chien, Chih-Yen, Fang, Fu-Min, Li, Shau-Hsuan, Luo, Sheng-Dean, Chiu, Tai-Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638984/ https://www.ncbi.nlm.nih.gov/pubmed/34855858 http://dx.doi.org/10.1371/journal.pone.0260772 |
Ejemplares similares
-
Low-Dose Aspirin Use Significantly Improves the Survival of Late-Stage NPC: A Propensity Score-Matched Cohort Study in Taiwan
por: Luo, Sheng-Dean, et al.
Publicado: (2020) -
Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis
por: Chen, Fu-An, et al.
Publicado: (2016) -
Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma
por: Luo, Sheng-Dean, et al.
Publicado: (2021) -
Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis
por: Wu, Chia-Che, et al.
Publicado: (2018) -
Effect of glycated hemoglobin A1c on the survival of patients with oral squamous cell carcinoma: A multi-institutional database cohort study
por: Chao, Chun-Yuan, et al.
Publicado: (2022)